Compounds > plerixafor
Page last updated: 2024-08-24

plerixafor and Alveolitis, Fibrosing

plerixafor has been researched along with Alveolitis, Fibrosing in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guidot, DM; Marts, LT; Sueblinvong, V1
Aono, Y; Azuma, M; Izumi, K; Kawano, H; Kinoshita, K; Kishi, J; Kishi, M; Makino, H; Nishioka, Y; Ogawa, H; Sone, S; Takezaki, A; Uehara, H; Yokota, Y1
Gao, H; Hao, C; Hong, S; Nayra, C; Rojas, M; Shim, H; Shu, HK; Torres-Gonzalez, E; Xu, K; Yoon, Y1
Kang, CM; Kang, HH; Kim, KH; Kim, YK; Moon, HS; Park, SH; Song, JS; Yoon, HK1
Arimura, K; Higashimoto, I; Matsuyama, W; Mitsuyama, H; Noma, S; Oonakahara, K; Osame, M; Shirahama, Y; Watanabe, M1

Other Studies

5 other study(ies) available for plerixafor and Alveolitis, Fibrosing

ArticleYear
HIV-1 Protein gp120 Induces Mouse Lung Fibroblast-to-Myofibroblast Transdifferentiation via CXCR4 Activation.
    The American journal of the medical sciences, 2019, Volume: 357, Issue:6

    Topics: Actins; Animals; Benzylamines; Cell Transdifferentiation; Cyclams; Female; Fibroblasts; Heterocyclic Compounds; HIV Envelope Protein gp120; Hydroxyproline; Male; MAP Kinase Signaling System; Mice, Transgenic; Pulmonary Fibrosis; Receptors, CXCR4

2019
Antifibrotic effects of CXCR4 antagonist in bleomycin-induced pulmonary fibrosis in mice.
    The journal of medical investigation : JMI, 2013, Volume: 60, Issue:1-2

    Topics: Animals; Benzylamines; Bleomycin; Cell Movement; Chemokine CXCL12; Chemotaxis; Cyclams; Female; Heterocyclic Compounds; Mice; Mice, Inbred C57BL; Pulmonary Fibrosis; Receptors, CXCR4

2013
Inhibition of the CXCL12/CXCR4-axis as preventive therapy for radiation-induced pulmonary fibrosis.
    PloS one, 2013, Volume: 8, Issue:11

    Topics: Animals; Benzylamines; Chemokine CXCL12; Cyclams; Disease Models, Animal; Female; Heterocyclic Compounds; Lung; Mesenchymal Stem Cells; Mice; Pulmonary Fibrosis; Pyrimidines; Radiation Injuries; Radiation Injuries, Experimental; Receptors, CXCR4; Tomography, X-Ray Computed

2013
Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis.
    Experimental & molecular medicine, 2010, Jun-30, Volume: 42, Issue:6

    Topics: Animals; Benzylamines; Bleomycin; Bronchoalveolar Lavage Fluid; Cell Movement; Cells, Cultured; Chemokine CXCL12; Cyclams; Cytoprotection; Down-Regulation; Drug Evaluation, Preclinical; Female; Heterocyclic Compounds; Lung; Mice; Mice, Inbred C57BL; Pulmonary Fibrosis; Receptors, CXCR4

2010
Dual effect of AMD3100, a CXCR4 antagonist, on bleomycin-induced lung inflammation.
    Journal of immunology (Baltimore, Md. : 1950), 2007, May-01, Volume: 178, Issue:9

    Topics: Animals; Anti-HIV Agents; Benzylamines; Bleomycin; Bronchoalveolar Lavage Fluid; Butadienes; Cyclams; Cytokines; Female; Heterocyclic Compounds; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neutrophils; Nitriles; Pneumonia; Pulmonary Fibrosis; Receptors, CXCR4

2007